u 73122 has been researched along with Cognition Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arancio, O; Chan, RB; Di Paolo, G; Duff, KE; Kim, TW; Laredo, M; Oliveira, TG; Shui, G; Staniszewski, A; Tian, H; Wang, L; Wenk, MR; Zhang, H | 1 |
1 other study(ies) available for u 73122 and Cognition Disorders
| Article | Year |
|---|---|
Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; Cell Line, Transformed; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Drug Interactions; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Estrenes; Excitatory Postsynaptic Potentials; Fear; Gene Expression Regulation; Green Fluorescent Proteins; Hippocampus; Humans; In Vitro Techniques; Long-Term Potentiation; Mass Spectrometry; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neurons; PC12 Cells; Peptide Fragments; Phospholipase D; Pyrrolidinones; Rats; Synapses; Time Factors | 2010 |